Frank Stokes
CFO & TreasurerMr. Frank Stokes has been Chief Financial Officer of Castle Biosciences Incorporated since December 4, 2017 and serves as its Treasurer. Mr. Stokes has been Independent Director at Exagen Inc. since June 17, 2021. Mr. Stokes has extensive experience leading capital formation for high-growth companies and was Chief Financial Officer of Hammock Pharmaceuticals from January 2017 to December 2017 and previously as a Managing Director of Leerink Swann from May 2011 to December 2016. He joined Castle Biosciences on December 4, 2017. He has financial accumen, expertise in capital markets, success with mergers and acquisitions and a deep knowledge of the diagnostics industry all of which helps team to continue the mission to improve patient care decisions and deliver shareholder value. Mr. Stokes joins Castle Biosciences with experience in finance. As Chief Financial Officer of Hammock Pharmaceuticals, he assisted in the initial capitalization of the company, as well as the acquisition of Hammock foundational drug delivery technology. Prior to Hammock, Mr. Stokes served as a Managing Director at Robert W. Baird and Wachovia Securities (now Wells Fargo Securities). Mr. Stokes received a B.S. in business administration followed by MBA and J.D. degrees from the University of North Carolina at Chapel Hill.
公司职务
- 公司名称Castle Biosciences, Inc.股票代码CSTL职务CFO & Treasurer共事同僚
- DJDerek J. MaetzoldFounder, CEO, President & Director
- DMDaniel Mark BradburyIndependent Chairman of the Board
- KMKristen M. OelschlagerChief Operating Officer
- TWTobin W. JuvenalChief Commercial Officer
- CZCamilla ZuckeroVice President of Investor Relations & Corporate Affairs
- GBGordon Bradley ColeIndependent Director
- TPTiffany P. OlsonIndependent Director
- EGEllen GoldbergIndependent Director
- 公司名称Exagen Inc.股票代码XGN职务Independent Director共事同僚
- TSTina S. NovaExecutive Chairman of the Board of Directors
- JAJohn AballiCEO, President & Director
- JGJeffrey G. BlackCFO & Corporate Secretary
- MMMichael MahlerChief Scientific Officer
- TJTina JacobsenVice President of Investor Relations
- AWArthur WeinsteinChairman of Scientific Advisory Board
- FSFrank StokesIndependent Director
- SDScott D. KahnIndependent Director
